Skip to main content
PMC home page
British Journal of Clinical Pharmacology logoLink to British Journal of Clinical Pharmacology
. 1975 Aug;2(4):311–315. doi: 10.1111/j.1365-2125.1975.tb02776.x

Isoprenaline antagonism of cardioselective beta-adrenergic receptor blocking agents on human and rat adipocytes.

H H Harms, J Van der Meer
PMCID: PMC1402598  PMID: 9950

Abstract

1. The beta-adrenergic blocking potencies of practolol, ICI 66082, tolamolol, acebutolol, H 93/26, H 87/07, pindolol and Ro 3-4787 were compared with that of propranolol, on human and rat adipocytes. 2. A good correlation was found between the potencies on adipocytes of the two species but not between our results and literature data on antagonism of isopernaline tachycardia in the anaesthetized cat. 3. The results indicate that differences between adrenergic beta-receptors in heart and adipose tissue may be detected using cardioselective beta-adrenergic receptor blocking agents.

Full text

PDF
313

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Ablad B., Carlsson E., Ek L. Pharmacological studies of two new cardioselective adrenergic beta-receptor antagonists. Life Sci I. 1973 Feb 1;12(3):107–119. doi: 10.1016/0024-3205(73)90368-8. [DOI] [PubMed] [Google Scholar]
  2. Adam K. R., Baird J. R., Burges R. A., Linnell J. The beta-blocking potency and cardioselectivity of tolamolol and its isomers in rodents. Eur J Pharmacol. 1974 Feb;25(2):170–175. doi: 10.1016/0014-2999(74)90046-6. [DOI] [PubMed] [Google Scholar]
  3. Arnold A. Differentiation of receptors activated by catecholamines. 3. Farmaco Sci. 1972 Jan;27(1):79–100. [PubMed] [Google Scholar]
  4. Barrett A. M., Carter J., Fitzgerald J. D., Hull R., Le Count D. A new type of cardioselective adrenoceptive blocking drug. Br J Pharmacol. 1973 Jun;48(2):340P–340P. [PMC free article] [PubMed] [Google Scholar]
  5. Basil B., Jordan R., Loveless A. H., Maxwell D. R. Beta-adrenoceptor blocking properties and cardioselectivity of M & B 17,803A. Br J Pharmacol. 1973 Jun;48(2):198–211. doi: 10.1111/j.1476-5381.1973.tb06906.x. [DOI] [PMC free article] [PubMed] [Google Scholar]
  6. Björntorp P., Ek L., Olsson S., Schröder G. The effect of a beta-adrenergic receptor antagonist (H 56-28) on lipid mobilization. Acta Pharmacol Toxicol (Copenh) 1967;25:51–62. [PubMed] [Google Scholar]
  7. Davey T., Malta E., Raper C. A comparison of the activities of the beta-adrenoceptor agonists MJ9184-1 AND (--)-ISOPRENALINE IN GUINEA-PIG AND CAT PREPARATIONS. Clin Exp Pharmacol Physiol. 1974 Jan-Feb;1(1):43–52. doi: 10.1111/j.1440-1681.1974.tb00525.x. [DOI] [PubMed] [Google Scholar]
  8. Grana E., Lucchelli A., Zonta F. Selectivity of beta-adrenergic compounds. III - Classification of beta-receptors. Farmaco Sci. 1974 Oct;29(10):786–792. [PubMed] [Google Scholar]
  9. Grana E., Mastelli O. C., Zonta F., Lucchelli A., Santagostino M. G. The selectivity of -adrenergic compounds. II. Studies on the mimetic compound Salbutamol and the lytic compound practolol. Farmaco Sci. 1972 Oct;27(10):842–854. [PubMed] [Google Scholar]
  10. Harms H. H., Zaagsma J., Van der Wal B. Beta-adrenoceptor studies. III. On the beta-adrenoceptors in rat adipose tissue. Eur J Pharmacol. 1974 Jan;25(1):87–91. doi: 10.1016/0014-2999(74)90098-3. [DOI] [PubMed] [Google Scholar]
  11. Kelly J. G., Shanks R. G. Adrenoceptors mediating metabolic responses in the greyhound. Br J Pharmacol. 1971 Feb;41(2):389P–390P. [PMC free article] [PubMed] [Google Scholar]
  12. Ko H., Royer M. E. A submicromolar assay for nonpolar acids in plasma and depot fat. Anal Biochem. 1967 Aug;20(2):205–214. doi: 10.1016/0003-2697(67)90026-7. [DOI] [PubMed] [Google Scholar]
  13. Lands A. M., Arnold A., McAuliff J. P., Luduena F. P., Brown T. G., Jr Differentiation of receptor systems activated by sympathomimetic amines. Nature. 1967 May 6;214(5088):597–598. doi: 10.1038/214597a0. [DOI] [PubMed] [Google Scholar]
  14. RODBELL M. METABOLISM OF ISOLATED FAT CELLS. I. EFFECTS OF HORMONES ON GLUCOSE METABOLISM AND LIPOLYSIS. J Biol Chem. 1964 Feb;239:375–380. [PubMed] [Google Scholar]
  15. Rowe M. J., Oliver M. F. Proceedings: Effect of nicotinic acid analogue on plasma free fatty acids and ventricular arrhythmias after myocardial infarction. Br Heart J. 1974 Oct;36(10):1037–1037. [PubMed] [Google Scholar]
  16. Stanton H. C. Selective metabolic and cardiovascular beta receptor antagonism in the rat. Arch Int Pharmacodyn Ther. 1972 Apr;196(2):246–258. [PubMed] [Google Scholar]

Articles from British Journal of Clinical Pharmacology are provided here courtesy of British Pharmacological Society

RESOURCES